Keyphrases
Peruvian
100%
Tuberculosis Patients
100%
Cytochrome P450 2E1 (CYP2E1)
100%
N-acetyltransferase 2 (NAT2)
100%
Genotype Frequency
100%
Allele Frequency
100%
Arylacetamide Deacetylase
100%
Poor Metabolizer
28%
Peru
14%
High Prevalence
14%
Antituberculosis Treatment
14%
Multidrug-resistant
14%
Genotype
14%
Drug-induced Liver Injury
14%
SNP
14%
Rs1799930
14%
Rs1801280
14%
African American Population
14%
Hepatotoxicity
14%
Korean Population
14%
Metabolizer Status
14%
Genetic Polymorphism
14%
National TB Program
14%
Drug Regimen
14%
Metabolic Proteins
14%
Multidrug Treatment
14%
European American
14%
TB Patients
14%
Japanese Population
14%
Anti-TB Drugs
14%
Genetic Diversity
14%
Treatment Failure
14%
Medicine and Dentistry
Acyltransferase
100%
CYP2E1
100%
Isoniazid
42%
Allele
28%
Prevalence
14%
Low Drug Dose
14%
Genetic Variability
14%
Genetic Polymorphism
14%
Toxic Hepatitis
14%
Liver Toxicity
14%
Single Nucleotide Polymorphism
14%
Biochemistry, Genetics and Molecular Biology
CYP2E1
100%
N-Acetyltransferase 2
100%
Allele
28%
Prevalence
14%
Genetic Divergence
14%
Single Nucleotide Polymorphism
14%
Low Drug Dose
14%
Genetic Polymorphism
14%
Wild Type
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acyltransferase
100%
CYP2E1
100%
Isoniazid
42%
Prevalence
14%
Hepatotoxicity
14%
Toxic Hepatitis
14%
Neuroscience
Cytochrome P450 2E1
100%
N-Acetyltransferase
100%
Isoniazid
42%
Genetic Polymorphism
14%
Immunology and Microbiology